Canada markets open in 9 hours 8 minutes

Poniard Pharmaceuticals, Inc. (PARD)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00010.0000 (0.00%)
At close: 03:13PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 434.76k
Enterprise Value 434.76k
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.10
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.03

Trading Information

Stock Price History

Beta (5Y Monthly) -35.48
52-Week Change 3-99.00%
S&P500 52-Week Change 323.57%
52 Week High 30.0100
52 Week Low 30.0001
50-Day Moving Average 30.0047
200-Day Moving Average 30.0087

Share Statistics

Avg Vol (3 month) 32
Avg Vol (10 day) 3N/A
Shares Outstanding 51.5M
Implied Shares Outstanding 63B
Float 8N/A
% Held by Insiders 10.00%
% Held by Institutions 10.00%
Shares Short (Nov 30, 2011) 447.72k
Short Ratio (Nov 30, 2011) 42.56
Short % of Float (Nov 30, 2011) 44.11%
Short % of Shares Outstanding (Nov 30, 2011) 43.18%
Shares Short (prior month Oct 14, 2011) 43.73k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:40
Last Split Date 3Nov 23, 2011

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2010
Most Recent Quarter (mrq)Sept 30, 2011

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-46.03%
Return on Equity (ttm)-210.37%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -13.04M
Net Income Avi to Common (ttm)-16.23M
Diluted EPS (ttm)-0.0100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.98M
Total Cash Per Share (mrq)1.32
Total Debt (mrq)1.64M
Total Debt/Equity (mrq)52.61%
Current Ratio (mrq)0.76
Book Value Per Share (mrq)2.08

Cash Flow Statement

Operating Cash Flow (ttm)-10.46M
Levered Free Cash Flow (ttm)-4.53M